What is it about?
Our research has shown that Semaphorin 4A (Sema4A) plays a significant role in modulating allergic responses. Specifically, Sema4A has been found to downregulate the severity of allergic airway inflammation. Key Findings Experimental Models: Studies using Sema4A-deficient (Sema4A⁻/⁻) mice in models of allergen-induced asthma have shown increased eosinophilic airway infiltration and bronchial epithelial cell hyperplasia compared to wild-type mice. Cytokine Production: The absence of Sema4A leads to higher levels of interleukin 13 (IL-13) in bronchoalveolar lavage fluid, which is associated with enhanced airway hyperreactivity. Regulatory T Cells (Tregs): Sema4A⁻/⁻ mice exhibit lower numbers of regulatory T cells, which are crucial for maintaining immune tolerance and controlling inflammation. Th2 Response: Sema4A-deficient CD4⁺ T cells are more effective in transferring a T helper type 2 (Th2) response, which is typically associated with allergic reactions. Mechanism Sema4A interacts with receptors such as Tim-2 on T cells and Plexin D1 on other cell types, influencing various immune responses.
Featured Image
Why is it important?
Sema4A-mediated pathways play important roles in allergic asthma. By modulating these pathways, Sema4A helps to control the extent of inflammation and allergic reactions.
Perspectives
Our findings highlight the potential of targeting Sema4A in therapeutic strategies for allergic diseases like asthma.
Svetlana Chapoval
University of Maryland School of Medicine
Read the Original
This page is a summary of: Neuroimmune semaphorin 4A downregulates the severity of allergic response, Mucosal Immunology, July 2012, Elsevier,
DOI: 10.1038/mi.2012.18.
You can read the full text:
Contributors
The following have contributed to this page







